ExodusPoint Capital Management LP lessened its stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 29.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,176 shares of the biotechnology company’s stock after selling 8,988 shares during the period. […]
Arcturus Therapeutics Holdings Inc. , a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver.
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s share price traded down 4.8% during trading on Monday . The company traded as low as $23.56 and last traded at $23.67. 76,757 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 431,716 shares. The stock had previously closed […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been given a consensus recommendation of “Buy” by the four ratings firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock […]